Is Vertex Pharmaceuticals' Empire in Trouble? [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Vertex Pharmaceuticals essentially has a monopoly in this area. That's a good thing so long as the biotech can protect its business from new market entrants, but if it fails to do so, the company could encounter significant challenges. Is that where Vertex Pharmaceuticals is headed? Let's find out. Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The CF drug pipeline Several companies are developing newer CF medicines to compete with Vertex's. The list includes Krystal Biotech , whose candidate, KB407, has performed well in phase 1 studies. KB407 is a gene therapy that targets the underlying causes of CF and helps clear the thick mucus that accumulates in patients' organs while restoring lung function. Importantly, it could work for all CF patients, whereas Vertex Pharmaceuticals'
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Is Vertex Pharmaceuticals' Empire in Trouble? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Vertex Pharmaceuticals (VRTX) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "buy (b-)" to "hold (c+)".MarketBeat
- Vertex Pharmaceuticals (VRTX) was given a new $612.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.MarketBeat
- Vertex Pharmaceuticals (VRTX) Valuation Check After FDA Expands ALYFTREK And TRIKAFTA Use [Yahoo! Finance]Yahoo! Finance
- Vertex to Announce First Quarter 2026 Financial Results on May 4thBusiness Wire
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- VRTX's page on the SEC website